LEFT-VENTRICULAR FUNCTION AS AN IMPORTANT END-POINT OF THROMBOLYTIC TRIALS

被引：0
|
作者：
WHITE, HD
机构：
[1] Cardiovascular Research Unit, Green Lane Hospital, Auckland
来源：
JOURNAL OF INTERVENTIONAL CARDIOLOGY | 1992年 / 5卷 / 02期
关键词：
D O I：
10.1111/j.1540-8183.1992.tb00415.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：111 / 116
页数：6
相关论文
共 50 条
  • [1] MEASUREMENT OF LEFT-VENTRICULAR FUNCTION AS AN END-POINT IN TRIALS OF THROMBOLYTIC THERAPY
    SHEEHAN, FH
    CORONARY ARTERY DISEASE, 1990, 1 (01) : 13 - 22
  • [2] LEFT-VENTRICULAR FUNCTION AS AN END-POINT OF THROMBOLYTIC THERAPY
    NORRIS, RM
    WHITE, HD
    EUROPEAN HEART JOURNAL, 1990, 11 : 5 - 9
  • [3] USE OF LEFT-VENTRICULAR FUNCTION AS AN END-POINT OF THROMBOLYTIC THERAPY
    BASSAND, JP
    ANGUENOT, T
    CASSAGNES, J
    LUSSON, JR
    MACHECOURT, J
    WOLF, JE
    AMERICAN JOURNAL OF CARDIOLOGY, 1991, 68 (16): : E23 - E29
  • [4] LEFT-VENTRICULAR EJECTION FRACTION MAY NOT BE USEFUL AS AN END-POINT OF THROMBOLYTIC THERAPY COMPARATIVE TRIALS
    CALIFF, RM
    HARRELSONWOODLIEF, L
    TOPOL, EJ
    CIRCULATION, 1990, 82 (05) : 1847 - 1853
  • [5] THE EFFECT OF THROMBOLYTIC THERAPY ON LEFT-VENTRICULAR FUNCTION
    SATLER, LF
    HOOD, WP
    WHITLOW, PL
    REEVES, RC
    LOGIC, JR
    BAXLEY, WA
    RACKLEY, CE
    ROGERS, WJ
    CLINICAL RESEARCH, 1983, 31 (03): : A672 - A672
  • [6] Left ventricular hypertrophy as a surrogate end-point in hypertension
    Devereux, RB
    Okin, PM
    Roman, MJ
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 1999, 21 (5-6) : 583 - 593
  • [7] Regression of left ventricular hypertrophy as a surrogate end-point for morbid events in hypertension treatment trials
    Devereux, RB
    AgabitiRosei, E
    Dahlof, B
    Gosse, P
    Hahn, RT
    Okin, PM
    Roman, MJ
    JOURNAL OF HYPERTENSION, 1996, 14 : S95 - S101
  • [8] OVERVIEW OF PATENCY AS AN END-POINT OF THROMBOLYTIC THERAPY
    ANDERSON, JL
    AMERICAN JOURNAL OF CARDIOLOGY, 1991, 68 (16): : E11 - E16
  • [9] Regression of left ventricular hypertrophy as a surrogate end-point for morbid events in hypertension treatment trials - Discussion
    MacMahon, S
    Devereux, R
    Zanchetti, A
    AgabitiRosei, E
    Hansson, L
    Swales, JD
    JOURNAL OF HYPERTENSION, 1996, 14 : S101 - S102
  • [10] THROMBOLYTIC TREATMENT OF LEFT-VENTRICULAR THROMBI
    HERRMANN, KS
    TEBBE, U
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1988, 113 (45) : 1781 - 1781
12345